Trial Profile
Transdermal Use of Lisuride in Early Parkinson's Disease: A double blind, randomized, Placebo and Pramipexole controlled study to evaluate the efficacy and safety of Lisuride TTS.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Feb 2014
Price :
$35
*
At a glance
- Drugs Lisuride (Primary) ; Pramipexole
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- Acronyms TULEP-1
- Sponsors axxonis Pharma
- 22 Jul 2011 This trial is recruiting in Germany and Poland and has completed in Italy.
- 22 Jul 2011 New trial record